Hemoglobin Subunit Beta Gene Polymorphism rs33949930 T>C and Risk of Sickle Cell Disease—A Case Control Study from Tabuk (Northwestern Part of Saudi Arabia)
- 1 Prince Fahd Bin Sultan Research Chair, Division of Cancer Molecular Genetics, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Kingdom of Saudi Arabia
- 2 King Khaled Hospital, Ministry of Health, Tabuk, Kingdom of Saudi Arabia
- 3 Prince Fahd Bin Sultan Research Chair, Division of Cancer Molecular Genetics, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Kingdom of Saudi Arabia
Abstract
Background: Sickle cell disease and sickle cell trait are common erythrocyte disorders that are most often caused by a point mutation (rs334, designated HbS) in the hemoglobin beta gene (HBB); however of this fact, there is extreme variability in occurrence and clinical presentation of sickle cell disease which may be explained by some other genetic changes associated with the gene. In the present study we examined the association between HBB gene polymorphism rs33949930 T>C in the occurrence of sickle cell disease in Saudi Arabia population. Materials and Methods: A case control study of 100 sickle cell disease patients and 100 healthy controls from Tabuk, Saudi Arabia. HBB gene rs33949930 T>C polymorphism was analyzed using Allele specific polymerase chain reaction technique. Results: It was observed that the genotype percentages TT, TC and CC among the patients with sickle cell disease were 63.0%, 35.0% and 2.0% and healthy controls were 68.0%, 27.0% and 5.0% respectively. Allele frequency for T allele was observed to be fT = 0.20 and fT = 0.19, where as for C allele was fC = 0.80 and fC = 0.81 among cases and controls respectively (p = 0.29). Compared to the TT genotype, the odds ratio of 1.4 (95% CI 0.76 - 2.57), risk ratio of 1.2 (95% CI 0.86 - 1.65) and risk difference of 8.4 (-6.66 - 23.38) for heterozygous genotype of HBB rs33949930 T>C was observed in relation to sickle cell disease. In addition, some difference in the laboratory values was observed among sickle cell disease patients with the different variants of HBB gene rs33949930 T>C polymorphism, especially the carriers of heterozygous TC genotype; however, the difference doesn’t reach to statically significant number. Conclusion: Present study suggested that there was not any significant association between HBB gene rs33949930 T>C polymorphism and occurrence of sickle cell disease. However, the heterozygous TC genotype of the polymorphism showed some higher ratios among cases as compared to healthy control group.
- Weatherall, D.J. and Clegg, J.B. (2001) Inherited Haemoglobin Disorders: An Increasing Global Health Problem. Bulletin of the World Health Organization, 79, 704-712.
- Adewoyin, A.S. (2015) Management of Sickle Cell Disease: A Review for Physician Education in Nigeria (Sub-Saharan Africa). Anemia, 2015, Article ID: 791498. http://dx.doi.org/10.1155/2015/791498
- http://www.who.int/genomics/public/Maphaemoglobin.pdf
- Lehmann, H., Maranjian, G. and Mourant, A.E. (1963) Distribution of Sickle-Cell Hemoglobin in Saudi Arabia. Nature, 198, 492-493. http://dx.doi.org/10.1038/198492b0
- Al-Qurashi, M.M., El-Mouzan, M.I., Al-Herbish, A.S., Al-Salloum, A.A. and Al-Omar, A.A. (2008) The Prevalence of Sickle Cell Disease in Saudi Children and Adolescents. A Community-Based Survey. Saudi Medical Journal, 29, 1480-1483.
- AlHamdan, N.A., AlMazrou, Y.Y., Al Swaidi, F.M. and Choudhry, A.J. (2007) Premarital Screening for Thalassemia and Sickle Cell Disease in Saudi Arabia. Genetics in Medicine, 9, 372-377. http://dx.doi.org/10.1097/GIM.0b013e318065a9e8
- el-Hazmi, M.A. and Warsy, A.S. (1999) Appraisal of Sickle-Cell and Thalassaemia Genes in Saudi Arabia. Eastern Mediterranean Health Journal, 5, 1147-1153.
- el-Hazmi, M.A. (1992) Clinical and Haematological Diversity of Sickle Cell Disease in Saudi Children. Journal of Tropical Pediatrics, 38, 106-112. http://dx.doi.org/10.1093/tropej/38.3.106
- Steinberg, M.H. (2005) Predicting Clinical Severity in Sickle Cell Anaemia. British Journal of Haematology, 129, 465-481. http://dx.doi.org/10.1111/j.1365-2141.2005.05411.x
- Pule, G.D., Ngo Bitoungui, V.J., Chetcha Chemegni, B., Kengne, A.P., Antonarakis, S. and Wonkam, A. (2015) Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions. OMICS, 19, 627-631. http://dx.doi.org/10.1089/omi.2015.0124
- Wonkam, A., Ngo Bitoungui, V.J. and Ngogang, J. (2015) Perspectives in Genetics and Sickle Cell Disease Prevention in Africa: Beyond the Preliminary Data from Cameroon. Public Health Genomics, 18, 237-241. http://dx.doi.org/10.1159/000431020
- Mtatiro, S.N., Mgaya, J., Singh, T., Mariki, H., Rooks, H., Soka, D., Mmbando, B., Thein, S.L., Barrett, J.C., Makani, J., Cox, S.E. and Menzel, S. (2015) Genetic Association of Fetal-Hemoglobin Levels in Individuals with Sickle Cell Disease in Tanzania Maps to Conserved Regulatory Elements within the MYB Core Enhancer. BMC Medical Genetics, 16, 4. http://dx.doi.org/10.1186/s12881-015-0148-3